Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2025-12-28 @ 4:02 AM
Study NCT ID:
NCT00008866
Status:
WITHDRAWN
Last Update Posted:
2021-11-01
First Post:
2001-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | HIV-1 | View |
| None | Didanosine | View |
| None | Drug Therapy, Combination | View |
| None | Drug Administration Schedule | View |
| None | CD4-Positive T-Lymphocytes | View |
| None | Hydroxyurea | View |
| None | RNA, Viral | View |
| None | Genotype | View |
| None | Reverse Transcriptase Inhibitors | View |
| None | Anti-HIV Agents | View |
| None | Viral Load | View |